{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:11:17Z","timestamp":1785161477039,"version":"3.55.0"},"posted":{"date-parts":[[2026,7,23]]},"group-title":"Cancer Biology","reference-count":139,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"NIH NCI","award":["4R01CA274605-04"],"award-info":[{"award-number":["4R01CA274605-04"]}]},{"name":"NIH NIGMS","award":["5P20GM121316-09"],"award-info":[{"award-number":["5P20GM121316-09"]}]},{"name":"NIH NCI","award":["R01CA276846"],"award-info":[{"award-number":["R01CA276846"]}]},{"name":"NCI Cancer Center Support Grant","award":["P30CA36727"],"award-info":[{"award-number":["P30CA36727"]}]},{"name":"NCI Research Specialist","award":["R50CA211462"],"award-info":[{"award-number":["R50CA211462"]}]},{"name":"American Cancer Society Research Scholar Grant","award":["RSG-19-127-01-CSM"],"award-info":[{"award-number":["RSG-19-127-01-CSM"]}]},{"name":"NCI T32 Cancer Biology Training Grant","award":["T32CA009476"],"award-info":[{"award-number":["T32CA009476"]}]},{"name":"NIH NCI","award":["1R01CA263504-01"],"award-info":[{"award-number":["1R01CA263504-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,23]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                <jats:p>Treatment-emergent neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant disease arising in up to 20% of castration resistant prostate cancers, yet robust biologically relevant preclinical models remain scarce. Here, we describe a technical blueprint for establishing an integrated platform of patient-derived models from visceral and bone metastases collected through a prostate cancer rapid autopsy program (PC RAP). We report the establishment and characterization of patient-derived xenograft (PDX) models from liver metastasis tissue, liver and bone metastasis-derived organoid lines (PDOs), and corresponding patient-derived organoid xenograft (PDOX) models. In addition, we established, to our knowledge, the first mesenchymal stem cell (MSC) cultures derived from neuroendocrine prostate cancer (NEPC) bone metastases. The PDOs preserved intratumoral heterogeneity, displaying both CRPC-NE and CRPC-adenocarcinoma features. These organoids retained neuroendocrine identity across multiple passages, with transcriptomic profiles concordant with the original patient tissue and matched PDX models generated at our institution and at the National Cancer Institute (NCI Patient-Derived Models Repository). To model the bone metastatic microenvironment, we generated novel organoid-based New Approach Methodologies (NAMs) by co-culturing PDOs with iPSC-derived bone marrow organoids, establishing a physiologically relevant vascularized organotypic model of PC bone metastasis. To extend our studies in vivo, we established preclinical models using the liver and bone metastasis-derived organoid models. The PDOX models were tumorigenic and developed spontaneous lymph node metastases, providing clinically relevant models for investigating lethal NEPC biology. Together, these complementary patient-derived models provide a robust and versatile platform for investigating NEPC biology, metastatic progression, and evaluating new therapeutic strategies.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Graphical abstract<\/jats:title>\n                  <jats:fig id=\"ufig1\" position=\"float\" orientation=\"portrait\" fig-type=\"figure\">\n                    <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"740121v1_ufig1\" position=\"float\" orientation=\"portrait\"\/>\n                  <\/jats:fig>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Novel preclinical models of visceral and bone metastases established from a prostate cancer rapid autopsy program.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>This study is the first to establish mesenchymal stem cell cultures from NEPC bone metastases.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>PDOs preserve heterogeneity, showing both CRPC-NE and CRPC-Adeno features, with transcriptomic profiles concordant with originator tissue and PDX models.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>PC RAP-derived organoids are tumorigenic in vivo and generate spontaneous lymph node metastases.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>\n                <\/jats:sec>","DOI":"10.64898\/2026.07.22.740121","type":"posted-content","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:55:14Z","timestamp":1784814914000},"source":"Crossref","is-referenced-by-count":0,"title":["An Integrated Preclinical Platform for Lethal Neuroendocrine Prostate Cancer from Rapid Autopsy Bone and Liver Metastases"],"prefix":"10.64898","author":[{"given":"Borum","family":"Ryu","sequence":"first","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C","family":"Caffrey","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriya","family":"Sridhar","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S","family":"Johnson","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramia J","family":"Salloom","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabhilan","family":"Mohan","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Waldron","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Robotham","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan M","family":"Wilcox","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Costanzo-Garvey","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Taylor","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Talaska","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rhatigan","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan P","family":"Ly","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather C","family":"Smith","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustubh","family":"Datta","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K","family":"Batra","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A","family":"LaGrange","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Division of Medical Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A","family":"Teply","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Division of Medical Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh M","family":"Lele","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Hollingsworth","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Katherine","family":"Hyde","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Nebraska Center for Molecular Target Discovery and Development, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Ghosal","sequence":"additional","affiliation":[{"name":"Nebraska Center for Molecular Target Discovery and Development, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanben","family":"Meng","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Mechanical & Materials Engineering, University of Nebraska-Lincoln, Lincoln, NE, USA"},{"name":"Nebraska Center for Integrated Biomolecular Communications, University of Nebraska-Lincoln, Lincoln, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Rizzino","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian R","family":"Black","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Nebraska Center for Molecular Target Discovery and Development, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Grandgenett","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher Y","family":"Abdalla","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah M","family":"Cook","sequence":"additional","affiliation":[{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C","family":"Bergan","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Division of Medical Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-6373","authenticated-orcid":false,"given":"Grinu","family":"Mathew","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Nebraska Center for Molecular Target Discovery and Development, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026072706213737000_2026.07.22.740121v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043"},{"key":"2026072706213737000_2026.07.22.740121v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4016"},{"key":"2026072706213737000_2026.07.22.740121v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.09.003"},{"key":"2026072706213737000_2026.07.22.740121v1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704174"},{"key":"2026072706213737000_2026.07.22.740121v1.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.3553"},{"key":"2026072706213737000_2026.07.22.740121v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4045"},{"key":"2026072706213737000_2026.07.22.740121v1.7","doi-asserted-by":"publisher","DOI":"10.1177\/1756287214528557"},{"issue":"6","key":"2026072706213737000_2026.07.22.740121v1.8","first-page":"2913","article-title":"Establishment and identification of small cell lung cancer cell lines having classic and variant features","volume":"45","year":"1985","journal-title":"Cancer Res"},{"key":"2026072706213737000_2026.07.22.740121v1.9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.16.1223"},{"issue":"2","key":"2026072706213737000_2026.07.22.740121v1.10","first-page":"225","article-title":"Molecular genetic characterization of neuroendocrine lung cancer cell lines","volume":"15","year":"1995","journal-title":"Anticancer Res"},{"key":"2026072706213737000_2026.07.22.740121v1.11","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07103"},{"key":"2026072706213737000_2026.07.22.740121v1.12","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23313"},{"key":"2026072706213737000_2026.07.22.740121v1.13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0409"},{"key":"2026072706213737000_2026.07.22.740121v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2013.11.012"},{"key":"2026072706213737000_2026.07.22.740121v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3944"},{"key":"2026072706213737000_2026.07.22.740121v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nature07935"},{"key":"2026072706213737000_2026.07.22.740121v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.03.053"},{"key":"2026072706213737000_2026.07.22.740121v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.12.021"},{"key":"2026072706213737000_2026.07.22.740121v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.11.010"},{"key":"2026072706213737000_2026.07.22.740121v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4438"},{"key":"2026072706213737000_2026.07.22.740121v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.016"},{"key":"2026072706213737000_2026.07.22.740121v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.017"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s13063-018-3039-z","article-title":"Supporting breast cancer screening decisions for caregivers of older women with dementia: study protocol for a randomized controlled trial","volume":"19","year":"2018","journal-title":"Trials"},{"key":"2026072706213737000_2026.07.22.740121v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04136-5"},{"key":"2026072706213737000_2026.07.22.740121v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jbo.2012.11.002","article-title":"The role of the bone microenvironment in skeletal metastasis","volume":"2","year":"2013","journal-title":"J Bone Oncol"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/PAP.0000000000000219","article-title":"Paget\u2019s \u201cSeed and Soil\u201d Theory of Cancer Metastasis: An Idea Whose Time has Come","volume":"26","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"2026072706213737000_2026.07.22.740121v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.327"},{"key":"2026072706213737000_2026.07.22.740121v1.29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6880"},{"key":"2026072706213737000_2026.07.22.740121v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.08.011"},{"key":"2026072706213737000_2026.07.22.740121v1.31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870515)59:10<1803::AID-CNCR2820591019>3.0.CO;2-X"},{"issue":"3 Pt 2","key":"2026072706213737000_2026.07.22.740121v1.32","first-page":"804","article-title":"Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients","volume":"147","year":"1992","journal-title":"J Urol"},{"key":"2026072706213737000_2026.07.22.740121v1.33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3791"},{"key":"2026072706213737000_2026.07.22.740121v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26042-z"},{"key":"2026072706213737000_2026.07.22.740121v1.35","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2019.0062"},{"key":"2026072706213737000_2026.07.22.740121v1.36","doi-asserted-by":"crossref","unstructured":"Restivo, G. , et al., Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq . Commun Biol, 2022. 5(1): p. 1144.PMC9616892","DOI":"10.1038\/s42003-022-04025-0"},{"key":"2026072706213737000_2026.07.22.740121v1.37","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197708)40:2<773::AID-CNCR2820400226>3.0.CO;2-I"},{"key":"2026072706213737000_2026.07.22.740121v1.38","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0557"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13000-021-01096-1","article-title":"Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases","volume":"16","year":"2021","journal-title":"Diagn Pathol"},{"key":"2026072706213737000_2026.07.22.740121v1.40","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000208"},{"issue":"12","key":"2026072706213737000_2026.07.22.740121v1.41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/cncy.21765","article-title":"Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers","volume":"124","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"2026072706213737000_2026.07.22.740121v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/nature01075"},{"key":"2026072706213737000_2026.07.22.740121v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.005"},{"key":"2026072706213737000_2026.07.22.740121v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(83)90147-4"},{"key":"2026072706213737000_2026.07.22.740121v1.45","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10662"},{"key":"2026072706213737000_2026.07.22.740121v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1528"},{"key":"2026072706213737000_2026.07.22.740121v1.47","doi-asserted-by":"crossref","unstructured":"Humphrey, P.A ., Histopathology of Prostate Cancer. Cold Spring Harb Perspect Med, 2017. 7(10).PMC5629988","DOI":"10.1101\/cshperspect.a030411"},{"issue":"4","key":"2026072706213737000_2026.07.22.740121v1.48","first-page":"367","article-title":"Lung cancer cytology: potential pitfalls and mimics - a review","volume":"3","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"2026072706213737000_2026.07.22.740121v1.49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/1742-6413.86816","article-title":"The cytomorphologic spectrum of small-cell carcinoma and large-cell neuroendocrine carcinoma in body cavity effusions: A study of 68 cases","volume":"8","year":"2011","journal-title":"Cytojournal"},{"issue":"6","key":"2026072706213737000_2026.07.22.740121v1.50","first-page":"3332","article-title":"Small cell carcinoma of the endometrium: a case report with emphasis on the cytological features","volume":"7","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"2026072706213737000_2026.07.22.740121v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.09.002"},{"key":"2026072706213737000_2026.07.22.740121v1.52","doi-asserted-by":"publisher","DOI":"10.4161\/cc.8.7.8043"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.53","doi-asserted-by":"crossref","first-page":"e55062","DOI":"10.1371\/journal.pone.0055062","article-title":"Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"2026072706213737000_2026.07.22.740121v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.006"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.celrep.2018.03.032","article-title":"Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells","volume":"23","year":"2018","journal-title":"Cell Rep"},{"key":"2026072706213737000_2026.07.22.740121v1.56","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201902048"},{"key":"2026072706213737000_2026.07.22.740121v1.57","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0597-8"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","article-title":"Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer","volume":"39","year":"2019","journal-title":"Cancer Commun (Lond"},{"key":"2026072706213737000_2026.07.22.740121v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20962-6"},{"key":"2026072706213737000_2026.07.22.740121v1.60","doi-asserted-by":"publisher","DOI":"10.1080\/14653240600855905"},{"issue":"14","key":"2026072706213737000_2026.07.22.740121v1.61","first-page":"5652","article-title":"Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway","volume":"61","year":"2001","journal-title":"Cancer Res"},{"key":"2026072706213737000_2026.07.22.740121v1.62","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-12"},{"key":"2026072706213737000_2026.07.22.740121v1.63","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23258"},{"issue":"12","key":"2026072706213737000_2026.07.22.740121v1.64","doi-asserted-by":"crossref","first-page":"165919","DOI":"10.1016\/j.bbadis.2020.165919","article-title":"Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2","volume":"1866","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2026072706213737000_2026.07.22.740121v1.65","doi-asserted-by":"crossref","unstructured":"Chan, W.C.W. , et al., Regulation and Role of Transcription Factors in Osteogenesis. Int J Mol Sci, 2021. 22(11).PMC8196788","DOI":"10.3390\/ijms22115445"},{"issue":"5","key":"2026072706213737000_2026.07.22.740121v1.66","first-page":"1891","article-title":"Acidic bone matrix proteins and their roles in calcification","volume":"17","year":"2012","journal-title":"Front Biosci (Landmark Ed"},{"key":"2026072706213737000_2026.07.22.740121v1.67","doi-asserted-by":"crossref","first-page":"144855","DOI":"10.1016\/j.gene.2020.144855","article-title":"Alkaline phosphatase: Structure, expression and its function in bone mineralization","volume":"754","year":"2020","journal-title":"Gene"},{"key":"2026072706213737000_2026.07.22.740121v1.68","doi-asserted-by":"crossref","unstructured":"Kim, J.M. , et al., Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells, 2020. 9(9).PMC7564526","DOI":"10.3390\/cells9092073"},{"key":"2026072706213737000_2026.07.22.740121v1.69","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.3389\/fimmu.2019.02182","article-title":"Chemokines in Physiological and Pathological Bone Remodeling","volume":"10","year":"2019","journal-title":"Front Immunol"},{"key":"2026072706213737000_2026.07.22.740121v1.70","doi-asserted-by":"crossref","first-page":"1100585","DOI":"10.3389\/fonc.2023.1100585","article-title":"Osteoid cell-derived chemokines drive bone-metastatic prostate cancer","volume":"13","year":"2023","journal-title":"Front Oncol"},{"key":"2026072706213737000_2026.07.22.740121v1.71","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0130"},{"key":"2026072706213737000_2026.07.22.740121v1.72","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1259"},{"key":"2026072706213737000_2026.07.22.740121v1.73","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-18-1101"},{"key":"2026072706213737000_2026.07.22.740121v1.74","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah4199"},{"key":"2026072706213737000_2026.07.22.740121v1.75","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah4307"},{"key":"2026072706213737000_2026.07.22.740121v1.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.05.006"},{"key":"2026072706213737000_2026.07.22.740121v1.77","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1982"},{"key":"2026072706213737000_2026.07.22.740121v1.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.001"},{"key":"2026072706213737000_2026.07.22.740121v1.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028"},{"key":"2026072706213737000_2026.07.22.740121v1.80","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.52940"},{"key":"2026072706213737000_2026.07.22.740121v1.81","first-page":"543272","article-title":"Review of small cell carcinomas of the prostate","volume":"2011","year":"2011","journal-title":"Prostate Cancer"},{"key":"2026072706213737000_2026.07.22.740121v1.82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053701"},{"issue":"11","key":"2026072706213737000_2026.07.22.740121v1.83","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.18632\/oncotarget.6029","article-title":"SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"2026072706213737000_2026.07.22.740121v1.84","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1263"},{"issue":"4","key":"2026072706213737000_2026.07.22.740121v1.85","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/jcp.29267","article-title":"Elevating SOX2 in prostate tumor cells upregulates expression of neuroendocrine genes, but does not reduce the inhibitory effects of enzalutamide","volume":"235","year":"2020","journal-title":"J Cell Physiol"},{"key":"2026072706213737000_2026.07.22.740121v1.86","doi-asserted-by":"crossref","unstructured":"Metz, E.P. , et al., Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells. Cancers (Basel), 2022. 14(8).PMC9025961","DOI":"10.3390\/cancers14081946"},{"key":"2026072706213737000_2026.07.22.740121v1.87","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2018.22"},{"key":"2026072706213737000_2026.07.22.740121v1.88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trsl.2018.12.008","article-title":"Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition","volume":"207","year":"2019","journal-title":"Transl Res"},{"key":"2026072706213737000_2026.07.22.740121v1.89","doi-asserted-by":"crossref","first-page":"1431362","DOI":"10.3389\/fonc.2024.1431362","article-title":"Targeting heme degradation pathway augments prostate cancer cell sensitivity to docetaxel-induced apoptosis and attenuates migration","volume":"14","year":"2024","journal-title":"Front Oncol"},{"key":"2026072706213737000_2026.07.22.740121v1.90","doi-asserted-by":"crossref","unstructured":"Salloom, R.J. , et al., Heme Oxygenase-1 and Prostate Cancer: Function, Regulation, and Implication in Cancer Therapy. Int J Mol Sci, 2024. 25(17).PMC11394971","DOI":"10.3390\/ijms25179195"},{"key":"2026072706213737000_2026.07.22.740121v1.91","doi-asserted-by":"crossref","first-page":"102339","DOI":"10.1016\/j.tranon.2025.102339","article-title":"Synergistic effects of HO-1 inhibition and chemotherapy on tumor proliferation and immune infiltration: An in vitro and in vivo approach to enhancing prostate cancer treatment","volume":"54","year":"2025","journal-title":"Transl Oncol"},{"key":"2026072706213737000_2026.07.22.740121v1.92","doi-asserted-by":"crossref","unstructured":"Diehn, M. , et al., Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature, 2009. 458(7239): p. 780-3.PMC2778612","DOI":"10.1038\/nature07733"},{"key":"2026072706213737000_2026.07.22.740121v1.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.12.012"},{"key":"2026072706213737000_2026.07.22.740121v1.94","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0199"},{"key":"2026072706213737000_2026.07.22.740121v1.95","doi-asserted-by":"crossref","unstructured":"Lam, C. , et al., PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4. Mol Cancer Ther, 2026","DOI":"10.1101\/2025.05.28.656643"},{"key":"2026072706213737000_2026.07.22.740121v1.96","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-00971-7"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.97","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/bloodadvances.2024013361","article-title":"Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment","volume":"9","year":"2025","journal-title":"Blood Adv"},{"key":"2026072706213737000_2026.07.22.740121v1.98","doi-asserted-by":"crossref","unstructured":"Schaefer, M.A. , et al., Applications of the Human Bone Marrow Organoid System to Study Hematopoiesis and Anemia Stress. Tissue Eng Part C Methods, 2026: p. 19373384261463760","DOI":"10.1177\/19373384261463760"},{"key":"2026072706213737000_2026.07.22.740121v1.99","doi-asserted-by":"publisher","DOI":"10.1007\/s11019-013-9480-6"},{"key":"2026072706213737000_2026.07.22.740121v1.100","doi-asserted-by":"publisher","DOI":"10.1002\/path.6271"},{"issue":"14","key":"2026072706213737000_2026.07.22.740121v1.101","first-page":"3369","article-title":"p53 is mutated in a subset of advanced-stage prostate cancers","volume":"53","year":"1993","journal-title":"Cancer Res"},{"key":"2026072706213737000_2026.07.22.740121v1.102","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990230206"},{"key":"2026072706213737000_2026.07.22.740121v1.103","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.20.1657"},{"key":"2026072706213737000_2026.07.22.740121v1.104","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.191"},{"key":"2026072706213737000_2026.07.22.740121v1.105","doi-asserted-by":"publisher","DOI":"10.1172\/jci132031"},{"key":"2026072706213737000_2026.07.22.740121v1.106","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01903-5"},{"key":"2026072706213737000_2026.07.22.740121v1.107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.06.053"},{"key":"2026072706213737000_2026.07.22.740121v1.108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902651116"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","article-title":"Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer","volume":"76","year":"2019","journal-title":"Eur Urol"},{"key":"2026072706213737000_2026.07.22.740121v1.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107669"},{"issue":"4","key":"2026072706213737000_2026.07.22.740121v1.111","first-page":"106","article-title":"Triple Aberrant Prostate Cancer (TAPC) - Aggregate role of aberrations in TP53, PTEN and RB1 on ETS gene fusions and prognosis in metastatic castrate resistant prostate cancer","volume":"8","year":"2020","journal-title":"Am J Clin Exp Urol"},{"key":"2026072706213737000_2026.07.22.740121v1.112","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0346"},{"issue":"7","key":"2026072706213737000_2026.07.22.740121v1.113","doi-asserted-by":"crossref","first-page":"110027","DOI":"10.1016\/j.celrep.2021.110027","article-title":"Combined whole-organ imaging at single-cell resolution and immunohistochemical analysis of prostate cancer and its liver and brain metastases","volume":"37","year":"2021","journal-title":"Cell Rep"},{"key":"2026072706213737000_2026.07.22.740121v1.114","doi-asserted-by":"crossref","unstructured":"Swamynathan, M.M. , et al., FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer. Cancers (Basel), 2023. 16(1).PMC10871093","DOI":"10.3390\/cancers16010060"},{"key":"2026072706213737000_2026.07.22.740121v1.115","doi-asserted-by":"crossref","unstructured":"Swamynathan, M.M. , et al., Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function. Science, 2024. 386(6720): p. eadk9167.PMC11975464","DOI":"10.1126\/science.adk9167"},{"key":"2026072706213737000_2026.07.22.740121v1.116","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-25-2747"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.117","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/s41467-026-69308-0","article-title":"Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity","volume":"17","year":"2026","journal-title":"Nature Communications"},{"key":"2026072706213737000_2026.07.22.740121v1.118","doi-asserted-by":"crossref","unstructured":"Singh, R. , et al., Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity. Nat Commun, 2026. 17(1).PMC13036044","DOI":"10.1038\/s41467-026-69308-0"},{"key":"2026072706213737000_2026.07.22.740121v1.119","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14284"},{"key":"2026072706213737000_2026.07.22.740121v1.120","doi-asserted-by":"crossref","first-page":"723707","DOI":"10.3389\/fonc.2021.723707","article-title":"The Origins and Generation of Cancer-Associated Mesenchymal Stromal Cells: An Innovative Therapeutic Target for Solid Tumors","volume":"11","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.121","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41420-022-01107-0","article-title":"Mesenchymal\/stromal stem cells: necessary factors in tumour progression","volume":"8","year":"2022","journal-title":"Cell Death Discov"},{"key":"2026072706213737000_2026.07.22.740121v1.122","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.21"},{"issue":"S1","key":"2026072706213737000_2026.07.22.740121v1.123","first-page":"S122","article-title":"Neuroendocrine tumors of the prostate","volume":"31","year":"2018","journal-title":"Mod Pathol"},{"issue":"13","key":"2026072706213737000_2026.07.22.740121v1.124","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/pros.23878","article-title":"Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer","volume":"79","year":"2019","journal-title":"Prostate"},{"issue":"12","key":"2026072706213737000_2026.07.22.740121v1.125","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1007\/s00261-020-02774-2","article-title":"Imaging of non-epithelial neoplasms of the prostate","volume":"45","year":"2020","journal-title":"Abdom Radiol (NY"},{"key":"2026072706213737000_2026.07.22.740121v1.126","doi-asserted-by":"publisher","DOI":"10.1186\/ar2104"},{"key":"2026072706213737000_2026.07.22.740121v1.127","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603030"},{"key":"2026072706213737000_2026.07.22.740121v1.128","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-015-9714-5"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41598-017-17800-5","article-title":"Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin","volume":"8","year":"2018","journal-title":"Sci Rep"},{"key":"2026072706213737000_2026.07.22.740121v1.130","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14606"},{"issue":"11","key":"2026072706213737000_2026.07.22.740121v1.131","doi-asserted-by":"crossref","first-page":"119101","DOI":"10.1016\/j.bbamcr.2021.119101","article-title":"Adipocyte-driven unfolded protein response is a shared transcriptomic signature of metastatic prostate carcinoma cells","volume":"1868","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"27","key":"2026072706213737000_2026.07.22.740121v1.132","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1038\/s41388-021-01874-7","article-title":"Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone","volume":"40","year":"2021","journal-title":"Oncogene"},{"key":"2026072706213737000_2026.07.22.740121v1.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.05.034"},{"key":"2026072706213737000_2026.07.22.740121v1.134","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16113"},{"issue":"4","key":"2026072706213737000_2026.07.22.740121v1.135","first-page":"263","article-title":"Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models","volume":"2","year":"2022","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"2026072706213737000_2026.07.22.740121v1.136","doi-asserted-by":"crossref","first-page":"21750","DOI":"10.1038\/s41598-020-78798-x","article-title":"Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease","volume":"10","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"2026072706213737000_2026.07.22.740121v1.137","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/hemato5030024","article-title":"The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax","volume":"5","year":"2024","journal-title":"Hemato"},{"issue":"8","key":"2026072706213737000_2026.07.22.740121v1.138","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/1541-7786.MCR-24-0672","article-title":"Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer","volume":"23","year":"2025","journal-title":"Mol Cancer Res"},{"issue":"3","key":"2026072706213737000_2026.07.22.740121v1.139","first-page":"1038","article-title":"Rapid (\u201cwarm\u201d) autopsy study for procurement of metastatic prostate cancer","volume":"6","year":"2000","journal-title":"Clin Cancer Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.07.22.740121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:22:24Z","timestamp":1785158544000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.07.22.740121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":139,"URL":"https:\/\/doi.org\/10.64898\/2026.07.22.740121","relation":{},"subject":[],"published":{"date-parts":[[2026,7,23]]},"subtype":"preprint"}}